Changchun Hiber Biotechnology

Changchun Hiber Biotechnology is a Chinese biopharmaceutical company specializing in the research, development, and large-scale production of recombinant protein therapeutics. Established in 2001 as a subsidiary of Changchun High-Tech Industries (Group) Inc., the company is a prominent manufacturer of interferon-based products in China. Its flagship product, Hibergen (Recombinant Human Interferon alpha-2b), is utilized for treating various viral infections and oncological conditions. The company operates advanced GMP-certified facilities in the Changchun High-Tech Industrial Development Zone and serves both the domestic Chinese market and international export markets. Hiber Biotechnology continues to focus on expanding its biological drug portfolio through internal R&D and manufacturing excellence.